Literature DB >> 15716296

Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients.

Alaattin Yildiz1, Esat Memisoglu, Huseyin Oflaz, Halil Yazici, Hamdi Pusuroglu, Vakur Akkaya, Faruk Erzengin, Savas Tepe.   

Abstract

BACKGROUND: Accelerated atherosclerosis and vascular calcification are common in chronic haemodialysis (HD) patients. In this study, we aimed to investigate the relationship between left ventricular hypertrophy (LVH) in HD patients and atherosclerosis and vascular calcification measured by electron beam computed tomography (EBCT).
METHODS: In a cohort of 118 HD patients (52 male, 66 female, mean age: 46+/-13 years), we measured biochemical parameters, including BUN, creatinine, albumin, haemoglobin, C-reactive protein and fibrinogen levels, and performed echocardiography, high-resolution B-mode carotid ultrasonography and EBCT in 85 of them. The degree of stenosis was measured at four different sites (communis, bulbus, interna and externa) in both carotid arteries. Carotid plaque scores were calculated by summing the degrees of stenosis measured at all locations.
RESULTS: LVH was detected in 89 of the patients (75%). Plaque-positive patients had higher left ventricular mass index (LVMI) than plaque-negative patients (175+/-59 vs 143+/-46 g/m2, P = 0.003). LVMI was correlated with systolic blood pressure (r = 0.62, P<0.001), pulse pressure (r = 0.58, P<0.001), haemoglobin levels (r = - 0.25, P = 0.008), carotid plaque score (r = 0.32, P = 0.001) and coronary (CACS) and aortic wall calcification score (AWCS) (r = 0.34, P = 0.002 and r = 0.43, P<0.001, respectively). Multiple linear regression analysis (model r = 0.76) showed the independent factors related to LVMI to be systolic blood pressure, pulse pressure, CACS and presence of carotid plaques.
CONCLUSION: Extra-coronary atherosclerosis and vascular calcification are associated with LVH in HD patients. Whether the treatment of atherosclerosis or vascular calcification may cause regression of or even prevent LVH in HD patients remains to be seen.

Entities:  

Mesh:

Year:  2005        PMID: 15716296     DOI: 10.1093/ndt/gfh611

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  22 in total

1.  Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature.

Authors:  A C Kalil; J Mattei; D F Florescu; J Sun; R S Kalil
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Electron-beam CT as a diagnostic modality in pediatric nephrology and renal transplant surgery.

Authors:  Ulf H Beier; Eunice John; Adisorn Lumpaopong; Jennifer G Co; Vladimir Jelnin; Enrico Benedetti; Giuliano Testa; Ramona Bottke; Bruce I Sharon; Carlos E Ruiz
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

3.  Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation.

Authors:  Ken Kitamura; Hideki Fujii; Kentaro Nakai; Keiji Kono; Shunsuke Goto; Tatsuya Nishii; Atsushi Kono; Shinichi Nishi
Journal:  Heart Vessels       Date:  2017-03-21       Impact factor: 2.037

4.  Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients.

Authors:  Paungpaga Lertdumrongluk; Elani Streja; Connie M Rhee; John J Sim; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-01       Impact factor: 8.237

5.  Hypervolemia rather than arterial calcification and extracoronary atherosclerosis is the main determinant of pulse pressure in hemodialysis patients.

Authors:  Halil Yazici; Huseyin Oflaz; Hamdi Pusuroglu; Savas Tepe; Cengiz Dogan; Ali Basci; Vakur Akkaya; Alaattin Yildiz
Journal:  Int Urol Nephrol       Date:  2011-07-05       Impact factor: 2.370

6.  Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.

Authors:  Ali Monfared; Arsalan Salari; Ehsan Kazemnezhad; Mohammadkazem Lebadi; Masoud Khosravi; Neda Kalantar Mehrjardi; Shahrzad Rahimifar; Nazly Amini
Journal:  Int Urol Nephrol       Date:  2013-01-11       Impact factor: 2.370

7.  Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Authors:  Mahmut Civilibal; Salim Caliskan; Sebuh Kurugoglu; Cengiz Candan; Nur Canpolat; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-11-04       Impact factor: 3.714

8.  Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.

Authors:  Rajan K Patel; Scott Oliver; Patrick B Mark; Joanna R Powell; Emily P McQuarrie; James P Traynor; Henry J Dargie; Alan G Jardine
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

Review 9.  Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.

Authors:  Dennis Andress
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Cardiovascular disease in patients with chronic kidney disease.

Authors:  Julian Wright; Alastair Hutchison
Journal:  Vasc Health Risk Manag       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.